Syngene announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited. The companies have entered into a binding term sheet and, on completion of the transaction, the site will add 20,000 liters of installed biologics drug substance manufacturing capacity for S…
TÜV SÜD, a leading provider of certification, auditing and testing services, officially opened its new state-of-the-art laboratory in New Brighton, Minnesota . The new laboratory is accredited to ISO 17025 for the biological and chemical testing of medical devices and is part of TÜV SÜD’s ongoing commitment to providi…
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has signed a Memorandum of Understanding (MOU) with the Government Pharmaceutical Organization (GPO), a state pharmaceutical enterprise in Thailand, to strengthen Thailand's …
BioNTX and grant partners Dallas College and the DFW Hospital Council Foundation collaborated with Swiss American CDMO to launch the Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT). The result of a United States Economic Development Administration jobs grant; the BHIANT brought together executi…
Azenta, Inc.announced it is opening a new location in the greater Boston area to expand its global sample storage business into the Boston market. The 40,000 square foot facility, located in Billerica, MA, will be Azenta's second largest biorepository in terms of sample capacity after its flagship Indianapolis locatio…
Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, announced the official opening of its latest Good Manufacturing Practice (GMP) facility in Singapore. The GMP will support cell manufacturing for immunotherapies in Singapore and across the …
Vertex and Lonza announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials. Vert…
Zimmer Biomet Holdings a global medical technology leader, officially opened an expanded office and APAC Global Business Services Center (GBS) in Kuala Lumpur, Malaysia. The momentous event was officiated by Datuk Muhammad Azmi Zulkifli, Chief Executive Officer of InvestKL and Bryan Hanson, Chairman, President and Ch…
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, is substantially extending its North American footprint and expanding global capacity with a new 200,000-square-foot manufacturing plant in Madison, Wisconsin – the second TekniPlex Healthcare facility in…
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland. The custom-built 5,500 square meter (60,000 square feet) Vaxxas Biomedical Facility will serve as the company…
Page 49 of 57